Lance Alstodt - Mar 18, 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Signature
/s/ Lance Alstodt
Stock symbol
BRTX
Transactions as of
Mar 18, 2024
Transactions value $
-$24,510
Form type
4
Date filed
3/20/2024, 04:36 PM
Previous filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Tax liability -$24.5K -17.6K -9.3% $1.39 172K Mar 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Stock Option 293K Mar 18, 2024 Common Stock 293K $5.08 Direct F2
holding BRTX Stock Option 42.1K Mar 18, 2024 Common Stock 42.1K $5.08 Direct F3
holding BRTX Stock Option 107K Mar 18, 2024 Common Stock 107K $2.91 Direct F4
holding BRTX Stock Option 439K Mar 18, 2024 Common Stock 439K $1.45 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld from vested stock grant to pay the associated withholding taxes.
F2 The option is currently exercisable.
F3 The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
F4 The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.
F5 The option vests and becomes exercisable to the extent of 219,298 shares on February 13, 2024 and 219,298 shares in eight nearly equal quarterly installments beginning February 13, 2025 and continuing every three months thereafter until fully vested.